Delivery Order SPE2DB20D2014-SPE2DB25FB20R
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,012.50, is a Delivery Order for the supply of HAVRIX 720 unit/0.5 mL syringes. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $18,540.74, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of July 10, 2024. Amerisourcebergen holds a...
This federal contract award is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $4,131.24 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. The contract is not set aside for any specific business type....
This federal contract award is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of the awardee, Amerisourcebergen Drug Corp. The contract has an estimated ceiling value of $3,919.80 and a period of performance through August 15, 2024. This is a delivery order issued under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential...
This federal contract award is for the supply of HAVRIX 720 unit/0.5 mL syringes to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $3,143.04, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 24, 2024. The contract is a delivery order with a firm fixed price and an ultimate completion date of April 25, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,707.31, is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML medical supplies. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 3, 2025. The award is not associated with a set-aside designation, indicating open competition....
This federal contract award is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,012.50 and is a Firm Fixed Price Delivery Order. It does not have a Set-Aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $30,871.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE/ML, a medical product, with a period of performance through March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,667.40 and an ultimate completion date of April 21, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award, valued at $2,306.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a vaccine product, with a completion date of December 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...